Skip to main content

Holiday schedule

Our Patient Service Centers will be closed on Friday, July 4, 2025 in observance of the Fourth of July holiday.  Have a healthy, happy holiday.

Hide
Quest Diagnostics

Identifying Ashkenazi Jewish Founder Variants in Combination With a Second Significant Finding

ACMG Annual Clinical Genetics Meeting, 2024

American College of Medical Genetics and Genomics

Toronto, Canada, March 12-16, 2024

Poster presentation: Identifying Ashkenazi Jewish Founder Variants in Combination With a Second Significant Finding

Authors: Basiliere MS, Nordquist EN, Weltmer EC

Specialty: Genetics, Oncology

Related content

On-Demand Webinar
Hereditary Cancer Care Starts in Primary Care
Publication
Targeted BRCA1/2 population screening among Ashkenazi Jewish individuals using a web-enabled medical model: An observational cohort study
Conference Presentation
Detection of Germline and Somatic BRCA Mutations Using a 50 Gene Next Generation Sequencing Panel

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.